A Phase 2B Study of Bms-790052 in Combinatin With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Grant uri icon

total award amount

  • 38445.46

direct costs

  • 30756.17

sponsor award ID

  • BMS A1444011-045

local award ID

  • 00078920